Friday, February 14, 2014

          Patent Trolling: Why Bio & Pharmaceuticals Are at Risk

          Groundbreaking study by Professor Robin Feldman and Harvard Fellow Dr. Nicholson Price show conventional wisdom is wrong when it comes to patent trolls, bio and pharma.
          Sample alt tag.
          Robin Feldman, Professor of Law and Director, Institute for Innovation Law

          Conventional wisdom holds that bio and pharma are safe from patent trolls. In a ground-breaking study, Professor Robin Feldman and Harvard Fellow Dr. Nicholson Price show that the conventional wisdom is wrong.

          The study is available for download via SSRN: Patent Trolling: Why Bio & Pharmaceuticals Are at Risk. Highlights include:

          • With the Association of University Technology Managers revisiting its policy against selling to NPEs, the authors considered whether universities could provide an extensive pool of ammunition for NPEs to launch against current products.
          • To supplement increasing anecdotal evidence that patent trolling is moving into bio and pharma, the authors examined the life science holdings of five major universities.We skimmed the patent holdings for four of the of five university systems with the highest number of patents issued in fiscal year 2011: the University of California system, the University of Texas system, MIT, and CalTech. We added as a wild-card the University of South Florida, the school among the top 10 in 2011 patent grants which had the lowest ratio of license revenues to research expenditures. 
          • The study identified dozens of patents that could be deployed against current bio and pharm industries, following the patterns that NPEs have used against other industries. These include patents on drug formulas, methods of treatments, research methods, dosage forms, and others.
          • In deciding whether to undertake the study, the authors agonized over whether the potential for harm outweighed the potential benefit. After all, if reform efforts are not undertaken, the work could simply provide a handy road map for those who would follow.
          • Life sciences trolling is predictable and in its infancy, however. The study is intended to sound a warning bell.

          About the Instititute for Innovation Law at UC Hastings

          The Institute for Innovation Law (Institute) is a public interest academic center at UC Hastings. The Institute engages in academic research and education to encourage innovation through the practice and development of law and policy. The Institute’s mission is to identify and promote the tools, knowledge, and skills needed to encourage innovation through the practice and development of law and policy.

          Media Contact

          Alex A.G. Shapiro
          Director, Communications & Public Affairs
          UC Hastings College of the Law
          Office: (415) 581-8842
          Cell: (415) 813-9214
          Email: shapiroa@uchastings.edu

          Go to News Archive

          Share this Story

          Share via Facebook
          Share via TwitterShare via EmailPrint Friendly Version

          Other Recent Stories/ RSS

          Friday, May 18, 2018

          UC Hastings Students Speak at UN Human Rights Council in Geneva

          Members of the Hastings Human Rights and International Law Organization attended the 37th Session of the United Nations Human Rights Council to meet diplomats, engage in discussions on human rights issues, and deliver advocacy statements during proceedings.
          Wednesday, May 09, 2018

          Joseph W. Cotchett, Champion for Justice and Titan of the Plaintiffs Bar, is UC Hastings Law's 2018 Commencement Speaker

          Litigation Trial Lawyers Hall of Famer and UC Hastings Alumnus, Class of 1964, to keynote the College’s 137th Commencement
          Friday, May 04, 2018

          Blek le Rat, “The Godfather” of Stencil Graffiti, Contributes Installation at UC Hastings

          The innovative street artist is taking to the streets with works throughout San Francisco to promote a rare North American exhibition.
          Friday, May 04, 2018

          UC Hastings Professor Veena Dubal’s Work Plays Role in California Supreme Court Ruling

          “The Dynamex Decision” creates a major change in the landscape for California’s gig economy and follows the path of Professor Dubal’s analysis from her scholarly work.
          Wednesday, May 02, 2018

          Thinkers & Doers: April 2018

          Professor Dubal cited in the California Supreme Court’s Dynamex decision – Professor Aviram discusses “Sanctuary City” litigation outside the Ninth Circuit – Ellen DeGeneres asks Kamala Harris about 2020 presidential aspirations – How Asylum Works and Doesn’t Work – Professor Ball earns national recognition with 2018 Shanara Gilbert Award – Highlights from the Spring Soirée – and much more
          Go to News Archive